We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Assay intended for use by professionals and trained operators on the SAMBA II instrument system in clinical and point-of-care settings.
The SAMBA II SARS-CoV-2/RSV test is for the qualitative detection of nucleic acids from SARS-CoV-2 and/or Respiratory Syncytial Virus in human respiratory specimens.
This page provides RPC guidance on how to produce a robust and evidence-based SaMBA.
This is the RPC's case histories section on the Small and Micro Business Assessment (SaMBA), updated August 2019.
This statement details the work HMRC is currently undertaking to eliminate modern slavery in our supply chains.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).